Journal
ACTA PHARMACEUTICA SINICA B
Volume 12, Issue 9, Pages 3567-3593Publisher
INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
DOI: 10.1016/j.apsb.2022.03.020
Keywords
Non-apoptotic cell death; Ferroptosis; Necroptosis; Pyroptosis; Autophagy; Nanomedicine; Combination therapies; Anticancer
Categories
Funding
- National Natural Science Foundation of China [51922111]
- Science and Technology Development Fund, Macau SAR (China) [0124/2019/A3]
- Guangdong-Hong Kong-Macao Joint Laboratory of Optoelectronic and Magnetic Functional Materials (China) [2019B121205002]
Ask authors/readers for more resources
Non-apoptotic cell death, such as ferroptosis, necroptosis, and pyroptosis, holds significant potential as an emerging cancer therapeutic target. Nanomedicine technology combined with different pathways and components can induce various forms of non-apoptotic cell death and achieve targeted and combination therapies.
As an emerging cancer therapeutic target, non-apoptotic cell death such as ferroptosis, ne-croptosis and pyroptosis, etc., has revealed significant potential in cancer treatment for bypassing apoptosis to enhance the undermined therapeutic efficacy triggered by apoptosis resistance. A variety of anticancer drugs, synthesized compounds and natural products have been proven recently to induce non-apoptotic cell death and exhibit excellent anti-tumor effects. Moreover, the convergence of nanotech-nology with functional materials and biomedicine science has provided tremendous opportunities to construct non-apoptotic cell death-based nanomedicine for innovative cancer therapy. Nanocarriers are not only employed in targeted delivery of non-apoptotic inducers, but also used as therapeutic compo-nents to induce non-apoptotic cell death to achieve efficient tumor treatment. This review first introduces the main characteristics, the mechanism and various pharmacological modulators of different non-apoptotic cell death forms, including ferroptosis, necroptosis, pyroptosis, autophagy, paraptosis, lysosomal-dependent cell death, and oncosis. Second, we comprehensively review the latest progresses of nanomedicine that induces various forms of non-apoptotic cell death and focus on the nanomedicine targeting different pathways and components. Furthermore, the combination therapies of non-apoptotic cell death with photothermal therapy, photodynamic therapy, immunotherapy and other modalities are summarized. Finally, the challenges and future perspectives in this regard are also discussed.(c) 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available